A Practical Approach to Uncomplicated Seizures in Children



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2000 Sep 1;62(5):1109-1116.

Uncomplicated seizures and epilepsy are common in infants and children. Family physicians should be aware of certain epilepsy syndromes that occur in children, such as febrile seizures, benign focal epilepsy of childhood, complex partial epilepsy, juvenile myoclonic epilepsy and video game–related epilepsy. Not all uncomplicated childhood seizures require neuroimaging or treatment. Febrile seizures, rolandic seizures and video game–related seizures are childhood epileptic syndromes that are typically not associated with brain structural lesions on computed tomography or magnetic resonance imaging, and are often not treated with anticonvulsant drugs. Juvenile myoclonic epilepsy does not require neuroimaging but does require treatment because of a high rate of recurrent seizures. Complex partial epilepsy often requires both neuroimaging and treatment. Although seizures are diagnosed primarily on clinical grounds, all children with a possible seizure (except febrile seizures) should have an electroencephalogram. Interictal EEGs may be normal. Computed tomography has demonstrated abnormalities in 7 to 19 percent of children with new-onset seizures. The yield of magnetic resonance imaging for specific childhood seizure types is not known, but it is the preferred modality of neuroimaging for many clinical presentations. Most children's seizures treated with anticonvulsants are controlled by the first drug selected. The value of “therapeutic” serum drug levels is questionable in the management of uncomplicated childhood seizures.

Seizures are a common childhood neurologic disorder. Approximately 4 to 10 percent of children have an unprovoked seizure without recurrence. Each year, about 150,000 children and adolescents have their first seizure and 30,000 of them are found to have epilepsy.1

Seizure Type vs. Epilepsy Syndrome

Determining the type of seizure, and whether it constitutes part of a specific epilepsy syndrome, is important for purposes of work-up, treatment and prognosis. The approach to a child with a new-onset seizure has two components. First, the physician should attempt to identify the specific type of seizure (i.e., tonicclonic or complex partial). Second, the physician should determine if the specific type of seizure is a component of an epilepsy syndrome.

An epilepsy syndrome, which is defined by seizure type(s), clinical findings and electroencephalographic (EEG) abnormalities, may require specific anticonvulsant drug treatment and is often associated with a predictable prognosis. This article discusses five epilepsy syndromes with which family physicians should be familiar (Table 1).

TABLE 1

Specific Epilepsy Syndromes Found in Children

Type Age of onset EEG findings Treatment

Febrile seizure

6 months to 6 years

Usually normal

Supportive measures Antipyretics

Benign focal (rolandic seizures)

3 to 13 years

Abnormal

Carbamazepine (Tegretol), valproic acid (Depakene)

Complex partial

Any age

Abnormal

Various anticonvulsants

Juvenile myoclonic epilepsy

12 to 18 years

Abnormal

Valproic acid

Video game–related epilepsy

Any age, although more typical in adolescents

About 50 percent abnormal

Abstinence from video games


EEG = electroencephalogram.

TABLE 1   Specific Epilepsy Syndromes Found in Children

View Table

TABLE 1

Specific Epilepsy Syndromes Found in Children

Type Age of onset EEG findings Treatment

Febrile seizure

6 months to 6 years

Usually normal

Supportive measures Antipyretics

Benign focal (rolandic seizures)

3 to 13 years

Abnormal

Carbamazepine (Tegretol), valproic acid (Depakene)

Complex partial

Any age

Abnormal

Various anticonvulsants

Juvenile myoclonic epilepsy

12 to 18 years

Abnormal

Valproic acid

Video game–related epilepsy

Any age, although more typical in adolescents

About 50 percent abnormal

Abstinence from video games


EEG = electroencephalogram.

Specific Epilepsy Syndromes

FEBRILE SEIZURES

Febrile seizures are benign seizure episodes that occur in approximately 3 percent of children between the ages of six months and six years (peak age: 18 to 24 months). Most are “simple”—i.e., single, brief (less than 15 minutes in duration) and generalized. Approximately one third are “complex”—i.e., multiple occurences within 24 hours, prolonged or focal. Neuroimaging tests are invariably normal, and EEGs are usually not helpful in predicting the need for treatment or the risk of recurrent febrile seizures or future epilepsy.2 Lumbar puncture should be considered in children with onset of febrile seizures before 18 months, because clinical meningeal signs may be absent at this age.2

The recurrence rate of simple febrile seizures is 30 percent, with a higher rate (50 percent) in those whose first seizure occurs before 12 months of age. There is no consistent evidence that simple febrile seizures cause brain injury or cognitive deficits, but they may be associated with subsequent epilepsy. Risk of epilepsy is approximately 2 to 4 percent in children with simple febrile seizures. The highest risk exists in children with prior abnormal neurodevelopmental status, family history of afebrile seizures and a complex feature.3 A careful history is essential to determining a complex feature, which is present in approximately one third of initial and recurrent febrile seizures.4

Treatment may reduce recurrences, but no study has demonstrated that treatment prevents later development of epilepsy. Most children with febrile seizures do not require anticonvulsant drugs5; however, counseling is needed to reassure parents about the absence of associated mortality and the low morbidity (primarily later epilepsy), as well as to educate them about methods to reduce possible harm during a seizure.

Effective treatments for reducing recurrences include oral diazepam (Valium) at the time of fever, daily phenobarbital or valproic acid (Depakene).5 Rectal diazepam (Diastat) also plays an important role in treatment, especially in stopping acute, prolonged seizures.6 If an anticonvulsant drug is used (e.g., multiple recurrences), the typical duration of therapy is one year, which represents the period with the highest risk of recurrence. It is prudent to recommend the use of antipyretics at the time of fever, but parents should be aware that these agents may not prevent seizure recurrences.5

BENIGN FOCAL EPILEPSY

Benign focal epilepsy of childhood (rolandic, centrotemporal spikes, sylvian) has its onset between three and 13 years of age and is one of the most common focal epilepsies in childhood.7 It is genetically inherited as an autosomal dominant trait with an age-dependant penetrance. The typical “focal” seizure lasts seconds to minutes and involves the mouth in sensory symptoms or focal twitching. A sudden inability to speak and drooling may occur. Children must be queried about these focal episodes because they are not associated with loss or alteration of consciousness, have no postictal phase and may be remembered by a child who may not have complained to a parent about previous episodes. Often, these children present for medical attention because of the high association (50 percent) with generalized seizures, which tend to be nocturnal or early-morning episodes.

EEGs can be helpful in diagnosis by demonstrating a specific pattern of high-amplitude spikes and waves in one or both centrotemporal areas. This epileptic syndrome is important to identify because it is “age-dependent;” seizures stop recurring by 14 to 16 years of age.7 If anticonvulsant therapy is used, these seizures can be effectively treated with carbamazepine (Tegretol). One bedtime dose may be all that is needed to control recurrences.

COMPLEX PARTIAL EPILEPSY

Complex partial (temporal lobe, psychomotor) epilepsy is a common type that occurs at any age. The frequency of seizures is highly variable. Alteration of consciousness typically occurs. Symptoms are myriad but tend to localize around the eyes (glassy-eyed, “drugged”, dazed, far-away look), the mouth (lip-smacking, drooling, gurgling) and the abdomen (nausea, vomiting, epigastric sensation).8 Most seizures last for several minutes and are associated with a postictal phase of confusion, sleep or headache. Secondary generalization can occur in up to one third of children. Thus, a witness to a child's generalized tonicclonic seizure should be queried about initial symptoms that suggest that the seizure's onset was complex partial in nature.

EEGs should include a study performed during sleep to maximize abnormalities. Magnetic resonance imaging (MRI) should be strongly considered to detect temporal lobe abnormalities, such as mesial temporal sclerosis, which might predict that the epilepsy may become refractory to medication.8 Complex partial epilepsy usually requires anticonvulsant drug therapy.

JUVENILE MYOCLONIC EPILEPSY

Juvenile myocolonic epilepsy, with onset between 12 and 18 years, consists of a “seizure triad”: generalized, absence and myoclonic, the latter occurring primarily in the morning.9 This epilepsy syndrome is postulated to be genetically inherited as an autosomal dominant trait with incomplete penetrance. The symptom of early-morning myoclonus, unassociated with alteration of consciousness, is often not mentioned by patients unless they are specifically questioned about it. The myoclonus may cause objects to “fly out of their hands,” cause repetitive flexion of the neck and shoulders or result in a fall.

Absence episodes mimic “petit mal” seizures. Generalized seizures are common and often occur on awakening; usually, however, it is only after questioning patients about myoclonus or absence episodes that the diagnosis of juvenile myoclonic epilepsy is suspected. In some patients, only two of the three “seizure types” are present.

Sleep deprivation easily provokes the seizures. EEG is helpful in diagnosis, demonstrating a generalized spike-polyspike and wave pattern in many patients, and a photo-convulsive effect in one third. It is important to diagnose this epileptic syndrome because up to one half of the patients have lifelong seizures and require prolonged anticonvulsant therapy. The drug of choice is valproicacid or divalproex (Depakote), which can be effective in reducing all three phenomena of the seizure triad.

VIDEO GAME–RELATED EPILEPSY

The precipitation of seizures by the flicker frequency of video games, although uncommon, is a frequent concern of parents. These seizures can occur with both full-screen and hand-held monitors.10 The seizure types vary and include generalized, simple or complex partial, or absence. One half of the patients have abnormal EEGs, often with a photoconvulsive effect. The most effective treatment is to abstain from playing video games, but anticonvulsant medical therapy should be strongly considered in those who have had other unprovoked seizures. Factors that may contribute to these seizures include screen brightness, sleep deprivation, fatigue, fever and short distance from the screen. Video game playing does not precipitate seizures in most people with epilepsy even if a photoconvulsive effect is seen on EEG.10

Value of EEG

The diagnosis of a seizure is based on the clinical history and not necessarily on the EEG. This neurologic tenet is based on the fact that many children with seizures have normal interictal EEGs. In addition, the sensitivity of an interictal EEG for different seizure types is highly variable. Only epilepsy syndromes such as absence epilepsy and infantile spasms are invariably associated with an abnormal EEG. The abnormal EEG findings that are most likely to correlate with clinical seizures include spikes or sharp waves, with or without concomitant slow waves, that are generalized, multifocal or localized to the temporal and frontal regions. Spikes in the occipital or central regions may not necessarily relate to clinical seizures in children.11

Although interictal EEGs are often normal in many types of childhood seizures, any child suspected of having a seizure (except febrile seizures) should have an EEG. Early EEG testing (within 24 to 48 hours of a seizure) may demonstrate more abnormalities.12 Serial EEGs (especially if performed after sleep deprivation and including one obtained during sleep) will increase the yield of abnormalities when the diagnosis cannot be established on a clinical basis. The severity of the EEG abnormality does not necessarily correlate with the clinical severity of the seizures. Routine follow-up EEGs generally do not serve any useful purpose in management, unless discontinuing anticonvulsant therapy is being considered. A normal or mildly abnormal EEG may indicate a good chance of remaining seizure free after anticonvulsant therapy is withdrawn.13

Up to 3 percent of children who have never had a seizure demonstrate abnormalities on their EEG, especially if there is evidence of neurologic injuries on neuroimaging, abnormal neurologic examination or neurodevelopmental evaluation, or a genetic predisposition to epilepsy.14 Several neurologic conditions, such as autism, pervasive developmental disorder and fragile X syndrome, are associated with severe EEG abnormalities in the absence of clinical seizures. The EEG can be helpful in ascertaining specific epileptic syndromes (e.g., benign focal epilepsy of childhood and juvenile myoclonic epilepsy) when the presenting seizure is nonspecific, as in tonicclonic seizures.

Value of Neuroimaging

Studies of children with seizures have demonstrated varying rates of abnormality on computed tomography (CT), especially abnormalities of therapeutic importance that may require additional neuroimaging studies or surgical intervention (Table 2).1519 Certain epileptic syndromes such as febrile seizures, absence epilepsy, benign focal epilepsy of childhood and juvenile myoclonic epilepsy are typically associated with normal results on neuroimaging.

TABLE 2

Computed Tomographic Findings in Children with Seizures

Study Number of children Seizure type Abnormal findings (%) Therapeutic significance (%)

Gilanz,15 1979

169

Idiopathic epilepsy

3.6

2.4

McAbee,16 1989

101

New-onset seizures/neurologically “normal” child

7

4

Warden,17 1997

203

New onset and recurrent presenting for emergency care

12

NR

Garvey,18 1998

99

New onset seizures/neurologically “normal” child presenting for emergency care

19

7

Stroink,19 1998

112

New onset unprovoked seizures

11

NR


NR = not reported.

Information from references 15 through 19.

TABLE 2   Computed Tomographic Findings in Children with Seizures

View Table

TABLE 2

Computed Tomographic Findings in Children with Seizures

Study Number of children Seizure type Abnormal findings (%) Therapeutic significance (%)

Gilanz,15 1979

169

Idiopathic epilepsy

3.6

2.4

McAbee,16 1989

101

New-onset seizures/neurologically “normal” child

7

4

Warden,17 1997

203

New onset and recurrent presenting for emergency care

12

NR

Garvey,18 1998

99

New onset seizures/neurologically “normal” child presenting for emergency care

19

7

Stroink,19 1998

112

New onset unprovoked seizures

11

NR


NR = not reported.

Information from references 15 through 19.

The ability of MRI to support diagnosis of specific seizure types is not yet known. However, MRI is considered to be more sensitive than CT in children because of its ability to detect developmental abnormalities in the brain. Limitations of MRI include an inability to detect calcification, which is important when a diagnosis of congenital infection, certain neurocutaneous disorders or certain tumors is being considered. In one study of children with new-onset complex partial epilepsy, nearly 40 percent had abnormalities on MRI.8 The most common finding was mesial temporal sclerosis, which is typically not detected on CT. MRI should be considered in children with refractory seizures, in those with temporal lobe epilepsy (even if CT findings are normal), in infants and young children (to detect developmental abnormalities not evident on CT) and when equivocal lesions are present on CT.

Anticonvulsant Drugs

Most children's seizures will be controlled by the anticonvulsant drug that is initially selected. Side effects and compliance can be improved by starting the drug at a low dosage and increasing it slowly. If satisfactory control is not established within the first three to six months, another anticonvulsant drug should be added, with the eventual goal of eliminating the first agent and achieving monotherapy.20

Six new anticonvulsants have been introduced since 1993, some of which may become drugs of choice for some seizures in children21  (Table 3). Several are labeled by the U.S. Food and Drug Administration for the treatment of certain childhood seizures, although all are currently used in children.22 Other promising anticonvulsant drugs are expected to be released in the next several years.

TABLE 3

Newer Anticonvulsant Drugs

Drug, date FDA-labeled FDA-labeled for children Usual maintenance dosage Advantages Disadvantages Possible clinical uses

Felbamate (Felbatol), 1993

Lennox-Gastaut syndrome

15 to 45 mg per kg per day

Good efficacy Nonsedating

Relatively frequent aplastic anemia and liver failure

Highly refractory seizures

Gabapentin (Neurontin), 1994

Not labeled

30 to 90 mg per kg per day

Virtually no drug interactions Serum monitoring not needed

Low efficacy

Benign partial seizures

Lamotrigine (Lamictal), 1996

Lennox-Gastaut syndrome

1 to 15 mg per kg per day

Good efficacy Low incidence of dose-related side effects

Frequent rash, sometimes serious, may be more frequent with concomitant valproic acid therapy

Intractable seizures or replacement for drug with unacceptable side effects

Topiramate (Topamax), 1997

Partial seizures in children over 2 years of age

3 to 9 mg per kg per day

Good efficacy Low incidence of dose-related side effects

Possible cognitive-behavior side effects, weight loss, renal calculi (rare)

Monotherapy or add to ACD for partial seizures

Tiagabine (Gabitril), 1997

Not labeled

16 to 32 mg per day

Novel GABA-related mode of action

Efficacy not fully established

Same as lamotrigine

Zonisamide (Zonegran), 2000

Not labeled

100 to 400 mg per day

Once or twice daily dosing


FDA = U.S. Food and Drug Administration; ACD = anticonvulsant drug; GABA = γ aminobutyric acid.

TABLE 3   Newer Anticonvulsant Drugs

View Table

TABLE 3

Newer Anticonvulsant Drugs

Drug, date FDA-labeled FDA-labeled for children Usual maintenance dosage Advantages Disadvantages Possible clinical uses

Felbamate (Felbatol), 1993

Lennox-Gastaut syndrome

15 to 45 mg per kg per day

Good efficacy Nonsedating

Relatively frequent aplastic anemia and liver failure

Highly refractory seizures

Gabapentin (Neurontin), 1994

Not labeled

30 to 90 mg per kg per day

Virtually no drug interactions Serum monitoring not needed

Low efficacy

Benign partial seizures

Lamotrigine (Lamictal), 1996

Lennox-Gastaut syndrome

1 to 15 mg per kg per day

Good efficacy Low incidence of dose-related side effects

Frequent rash, sometimes serious, may be more frequent with concomitant valproic acid therapy

Intractable seizures or replacement for drug with unacceptable side effects

Topiramate (Topamax), 1997

Partial seizures in children over 2 years of age

3 to 9 mg per kg per day

Good efficacy Low incidence of dose-related side effects

Possible cognitive-behavior side effects, weight loss, renal calculi (rare)

Monotherapy or add to ACD for partial seizures

Tiagabine (Gabitril), 1997

Not labeled

16 to 32 mg per day

Novel GABA-related mode of action

Efficacy not fully established

Same as lamotrigine

Zonisamide (Zonegran), 2000

Not labeled

100 to 400 mg per day

Once or twice daily dosing


FDA = U.S. Food and Drug Administration; ACD = anticonvulsant drug; GABA = γ aminobutyric acid.

A few of the older anticonvulsant agents are now available in newer preparations. Rectal diazepam (Diastat), a gel in a single-dose syringe, is FDA-labeled for reducing the number of seizures in patients whose seizures occur in clusters.6 Because of its extremely low rate of respiratory compromise, this agent holds promise for other uses in the acute treatment of seizures. Carbamazepine, a drug of choice for many seizure types in children, is now available in two sustained-release preparations that permit twice-daily dosing. Carbatrol capsules can be opened and mixed with food or liquid. Tegretol XR tablets must be swallowed whole, can be given twice daily and are available in dosages of 100, 200 and 400 mg. Trileptal has fewer side effects and does not require monitoring of hepatic or hematologic parameters. Serum carbamazepine levels should be obtained when switching a patient to a sustained-release form because identical doses do not always produce equivalent serum levels.

‘Therapeutic’ Drug Levels

Changing the dosage of an anticonvulsant drug solely on the basis of a serum drug level is “like driving a car looking at the speedometer and not out the window. Wrecks are going to be frequent and inevitable.”23

The concept of the “therapeutic” drug level is frequently misunderstood. These levels are established by animal and human studies, the latter involving patients with refractory seizures who are generally taking multiple anticonvulsants. Thus, the serum drug concentration that is effective in a typical child with infrequent seizures has not yet been established and may be lower than the usual reported therapeutic level. For example, patients taking phenytoin have had seizures controlled with levels ranging from 5 to 25 mg per dL; the usual “therapeutic” range is 10 to 20 mg per dL.23

In general, starting dosages of anticonvulsants should be based on weight, age and intake of other medication, and should be individualized for each patient. Routinely increasing a dosage to reach a “magic” level might not be necessary to prevent recurrent seizures and might result in increased side effects.23 It should also be remembered that toxicity can occur at therapeutic levels, especially when more than one drug is used. Serum drug levels are primarily helpful in determining compliance, documenting a level at which a therapeutic failure (i.e., seizure) has occurred, analyzing drug-drug interactions and assessing side effects. For most anticonvulsants, serum levels need not be obtained on a routine or arbitrary basis, particularly if a child is seizure free and without side effects.24

It is important to tell parents that anticonvulsant therapy lowers the risk of recurrences (in some patients, to zero) but does not guarantee that a child will not have a seizure while taking the anticonvulsant, even if the serum level is in the therapeutic range. In addition, parents should also be aware that these drugs may prevent recurrences but do not alter the long-term prognosis for attaining seizure remission.

The Authors

GARY MCABEE, D.O., J.D., is associate professor of pediatrics (neurology) and chair of pediatrics at the University of Medicine and Dentistry of New Jersey (UMDNJ)–School of Osteopathic Medicine, Stratford. He is also an attending pediatric neurologist at Children's Regional Hospital at Cooper Hospital–University Medical Center, Camden, N.J. A graduate of the University of Osteopathic Medicine and Health Sciences, Des Moines, he holds a law degree from St. John's University School of Law, New York City. Dr. McAbee received pediatric training at New York Medical College, also in New York City, and training in pediatric neurology at Washington University School of Medicine/St. Louis Children's Hospital.

JAMES WARK, M.D., is chief of child neurology at Children's Regional Hospital at Cooper Hospital and an assistant professor of pediatrics in neurology at UMDNJ–Robert Wood Johnson School of Medicine, Camden. He received his medical degree at King's College School of Medicine and Dentistry, London. Following training in pediatrics at Queen's University, Kingston, Ontario, Dr. Wark specialized in pediatric neurology and served a fellowship in electroencephalographic research at the Hospital for Sick Children, Toronto.

Address correspondence to Gary N. McAbee, D.O., J.D., Division of Child Neurology, 3 Cooper Plaza, Suite 309, Camden, NJ 08103. Reprints are not available from the authors.

REFERENCES

1. Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia. 1994;35(suppl 2):S1–6.

2. Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. American Academy of Pediatrics. Provisional Committee on Quality Improvement, Subcommittee on Febrile Seizures. Pediatrics. 1996;97:769–75.

3. Annegers JF, Hauser WA, Shirts SB, Kurland LT. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med. 1987;316:493–8.

4. Berg AT, Shinnar S. Complex febrile seizures. Epilepsia. 1996;37:126–33.

5. Practice parameter: long-term treatment of the child with simple febrile seizures. American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Febrile Seizures. Pediatrics. 1999;103:1307–9.

6. Dooley JM. Rectal use of benzodiazepines. Epilepsia. 1998;39(suppl 1):S24–7.

7. Wirrell EC. Benign epilepsy of childhood with centrotemporal spikes. Epilepsia. 1998;39(suppl 4):S32–41.

8. Harvey AS, Berkovic SF, Wrennall JA, Hopkins IJ. Temporal lobe epilepsy in children: clinical, EEG, and neuroimaging findings and syndrome classification in a cohort with new-onset seizures. Neurology. 1997;49:960–8.

9. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia. 1994;35:285–96.

10. Harding GF, Jeavons PM, Edson AS. Video material and epilepsy. Epilepsia. 1994;35:1208–16.

11. Mizrahi EM. Avoiding the pitfalls of EEG interpretation in childhood epilepsy. Epilepsia. 1996;37(suppl 1):S41–51.

12. King MA, Newton MR, Jackson GD, Fitt GJ, Mitchell LA, Silvapulle MJ, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet. 1998;352:1007–11.

13. Camfield C, Camfield P, Gordon K, Smith P, Dooley J. Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J Pediatr. 1993;122:861–8.

14. Cavazzuti GB, Capella L, Nalin A. Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia. 1980;21:43–55.

15. Gilsanz V, Strand R, Barnes P, Nealis J. [Results of presumed cryptogenic epilepsy in childhood by CT scanning]. Ann Radiol [Paris]. 1979;22:184–7.

16. McAbee GN, Barasch ES, Kurfist LA. Results of computed tomography in “neurologically normal” children after initial onset of seizures. Pediatr Neurol. 1989;5:102–6.

17. Warden CR, Brownstein DR, Del Beccaro MA. Predictors of abnormal findings of computed tomography of the head in pediatric patients presenting with seizure. Ann Emerg Med. 1997;29:518–23.

18. Garvey MA, Gaillard WD, Rusin JA, Ochsenschlager D, Weinstein S, Conry JA, et al. Emergency brain computed tomography in children with seizures: who is most likely to benefit? J Pediatr. 1998;133:664–9.

19. Stroink H, Brouwer OF, Arts WF, Geerts AT, Peters AC, Donselaar CA. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long-term outcome after recurrence. J Neurol Neurosurg Psych. 1998;64:595–600.

20. Guberman A. Monotherapy or polytherapy for epilepsy? Can J Neurol Sci. 1998;25:S3–8.

21. Bourgeois BF. New antiepileptic drugs. Arch Neurol. 1998;55:1181–3.

22. Pellock JM. Treatment of seizures and epilepsy in children and adolescents. Neurology. 1998;51:S8–14.

23. Dodson WE. Level off [Editorial]. Neurology. 1989;39:1009–10.

24. Pellock JM, Willmore LJ. Rational guide to routine blood monitoring in patients receiving antiepileptic drugs [Editorial]. Neurology. 1991;41:961–94.



Copyright © 2000 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in AFP

More in Pubmed

Navigate this Article